Revised forecast
Fiscal year ending March 2026 · Full yearPrevious forecast published 12 May 2025The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
Net sales and operating profit were revised downward because demand for major products is expected to fall short of assumptions, among other factors. Ordinary profit remains unchanged because foreign exchange gains and losses, net financial income and expenses, and other factors are expected to offset the decline in operating profit. Net income was revised downward due to additional extraordinary losses, including special retirement payments and losses resulting from the shortening of depreciation periods, associated with bringing forward the timing of the suspension or reduction of production in Thailand.
Details Additional extraordinary losses, including special retirement payments and losses resulting from the shortening of depreciation periods, associated with bringing forward the timing of the suspension or reduction of caprolactam and nylon polymer production in Thailand / Amount Not disclosed
| Item | Details |
|---|---|
| Net Sales | ¥490,000 million → ¥462,300 million（-5.7%） |
| Operating profit | ¥25,000 million → ¥18,900 million（-24.4%） |
| Ordinary income | ¥37,500 million → ¥37,500 million |
| Profit attributable to owners of the parent | ¥27,500 million → ¥23,900 million（-13.1%） |
| Net income per share | 283.15 yen and sen → 246.05 yen and sen |
| Fiscal Period Covered | Fiscal year ending March 2026 |
| Period Covered | Full year |
| Publication date of previous forecast | 12 May 2025 |
| Previous-period results | Fiscal Period Covered Fiscal year ended March 2025 / Net Sales 486,802 / Operating profit 18,045 / Ordinary income 22,372 / Profit attributable to owners of the parent -4,816 / Net income per share -49.6 / Profit and loss unit ¥ million / Earnings per share unit yen and sen |
| Reason for the revision | Net sales and operating profit were revised downward because demand for major products is expected to fall short of assumptions, among other factors. Ordinary profit remains unchanged because foreign exchange gains and losses, net financial income and expenses, and other factors are expected to offset the decline in operating profit. Net income was revised downward due to additional extraordinary losses, including special retirement payments and losses resulting from the shortening of depreciation periods, associated with bringing forward the timing of the suspension or reduction of production in Thailand. |
| Details and amount of extraordinary loss | Details Additional extraordinary losses, including special retirement payments and losses resulting from the shortening of depreciation periods, associated with bringing forward the timing of the suspension or reduction of caprolactam and nylon polymer production in Thailand / Amount Not disclosed |
| Dividend forecast revision | No change |
| Consolidated / non-consolidated | Consolidated |
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The forecasts for net sales and operating profit have been revised downward because demand for major products is expected to fall short of assumptions across all segments, including Functional Products and Resins and Chemicals. Ordinary profit remains unchanged because foreign exchange gains and losses, net financial income and expenses, and other factors are expected to offset the decline in operating profit. Net income has been revised downward due to additional extraordinary losses, including special retirement payments and the shortening of depreciation periods, following the decision to bring forward by one year the timing of the suspension or reduction of caprolactam and nylon polymer production in Thailand.